protein is detected until 24 wk of gestation, despite SP-B mRNA levels reaching 50% of adult levels by the end of The hydrophobic surfactant proteins (SP)-B and -C are the second trimester (11, 12). One potential mechanism for essential to the surface tension-reducing properties of pulthe developmental control of post-translational processing monary surfactant (reviewed in Refs. 1 and 2). Human is the developmental regulation of SP-B processing enpatients and transgenic mice deficient in SP-B succumb to zymes. We have shown previously that the post-translasevere respiratory failure, and both SP-B and SP-C are tional proteolysis of SP-B is induced during ex vivo maturaabsent from the alveolar surfactant (3, 4). Although the tion of type 2 cells in human lung explant culture (10). We absence of SP-B is due to genetic mutation, the absence of have also shown that the kinetics of the final steps in the mature 3.7-kD form of SP-C is a secondary effect. Both proSP-B processing are further accelerated by the addition of glucocorticoids, suggesting that the enzyme(s) required for SP-B processing are upregulated in their expression or (Received in original form July 10, 2002 and in revised form August 6, 2002) activated under these conditions. Cathepsin H, a cysteine protease with unique aminopepti-
have similarly shown that Cathepsin H is able to cleave Lung Explant and Primary Cell Culture both proSP-B and proSP-C recombinant proteins, resulting Human fetal lung obtained from second trimester therapeutic in protein fragments comparable in M r to endogenous interabortions (14-23 wk estimated gestational age) were obtained under protocols approved by the Committee for Human Research, mediates (14, 16 ).
Children's Hospital of Philadelphia. Tissues were frozen at - 70ЊC We now show that inhibition of cysteine protease activity for RNA and protein assays, fixed for immunohistochemistry (see in cultured human type 2 cells by E-64 blocks the final step below), or used for explant or cell culture as follows. Fetal lung of SP-B processing, resulting in accumulation of the 9-kD parenchyma was dissected free of large airways, chopped into 1 intermediate. Furthermore, cysteine protease inhibition by mm 3 explants, and cultured in Waymouth media on a rocking E-64 during in vitro differentiation of human type 2 cells platform as previously described (17) . After overnight culture as interrupts SP-B processing and leads to additional features explants, epithelial cells were isolated by digestion with trypsin, of SP-B deficiency, including abnormal SP-C processing collagenase, and DNase, followed by panning on plastic culture and aberrant lamellar bodies. Through the use of reverse dishes to remove adherent fibroblasts as described previously (18) .
transcriptase-polymerase chain reaction (RT-PCR)s and
Cells were then cultured for up to 7 d in 10 nM dexamethasone, and 0.1 mM 8-Br-cAMP and 0.1 mM isobutylmethylxanthine (DCI) to
Western immunoblotting, we show that Cathepsin H exinduce type 2 cell differentiation. To isolate fully differentiated pression is upregulated during type 2 cell differentiation type 2 cells, explants were cultured in DCI for 4 d followed by
and, by immunoelectron microscopy, that Cathepsin H and isolation of epithelial cells by enzymatic digestion and panning to SP-B both localize in multivesicular bodies, composite bodremove fibroblasts as previously described (19) . The cells were ies, and lamellar bodies. Together, these data suggest that cultured an additional 4 d in Waymouth media supplemented with cysteine protease activity, likely from Cathepsin H, plays an DCI in 95% air, 5% CO2.
integral role in SP-B processing and lamellar body genesis.
Materials and Methods

Pulse:Chase Labeling and Immunoprecipitation Reagents
We prepared fully differentiated type 2 cells from hormone-stimulated lung explants as described above. Culture medium was reExpress Protein Labeling Mix was obtained from New England placed with DCI-supplemented Waymouth medium ϩ DMSO or Nuclear (Boston, MA). Protein A-agarose was obtained from Life E-64 at 10-100 M for overnight culture. Cells were then incubated Technologies, Inc. (Gaithersburg, MD). Dexamethasone, isobutylin Met-Cys-free Dulbecco's modified Eagle's media (DMEM; 2 methylxanthine, 8-Br-cAMP, E-64, and dimethylsulfoxide (DMSO) ml/60 mm plate) Ϯ E-64 for 1 h. Met-Cys-free media was replaced were obtained from Sigma Chemical Co. (St. Louis, MO). All with Met-Cys-free DMEM Ϯ E-64 supplemented with 200 Ci/ other reagents were electrophoretic grade and were purchased ml of 35 S Express Protein Labeling Mix that is composed of 70% from either Bio-Rad Laboratories (Hercules, CA) or Invitrogen methionine and 15% cysteine (New England Nuclear). After a 30-(Carlsbad, CA). Culture media were produced by the Cell Center min pulse, the media was changed to complete Waymouth media Facility, University of Pennsylvania School of Medicine.
with DCI Ϯ E-64. Samples were harvested immediately after the Western immunoblotting and immunocytochemistry studies 35 S labeling and at regular intervals through 4 h post-labeling. were performed using rabbit polyclonal antisera to human SP-A, Samples were washed in phosphate-buffered saline (PBS) with human SP-B, NFlank (the aminoterminal propeptide of human protease inhibitors (10 mM N-ethyl maleimide, 2 mM benzamidine proSP-B amino acids Gln , which have been charprecipitated as previously described for SP-B (6). Electrophoresed acterized elsewhere (5, 10) , rabbit polyclonal antiserum to Cathepsamples were transferred to membrane and blots were visualized sin H (Athens Research and Technology, Athens, GA), and a using the Storm phosphorimager system (Molecular Dynamics, mouse monoclonal antibody to glyceraldehyde phosphate dehySunnyvale, CA). drogenase (GAPDH; Chemicon, St. Louis, MO). To identify subcellular organelles, we used the following antisera: mouse monoclonal antibody to the BiP (StressGen Biotechnologies Corp., Victoria, BC, Canada) for endoplasmic reticulum, mouse mono-
Toxicity Studies
clonal antibody to p230 for Golgi, and mouse monoclonal antibody In addition to examining 35 S-Met/Cys incorporation into TCA preto EEA1 for early endosomes (Transduction Laboratories, Lexingcipitable proteins (see above), toxicity was assessed by labeling ton, KY), and mouse monoclonal antibody to Lamp-1 for multivelive cells with Carboxy-SNARF-1, a long-wavelength fluorescent sicular body, LB, and lysosomes (H4A3 developed by J. T. August pH indicator (Molecular Probes, Eugene, OR). Cells were washed and J. E. K. Hildreth from the Developmental Studies Hybridoma in PBS and then incubated with 2 M Carboxy-SNARF-1 in PBS Bank; developed under the auspices of the NICHD and maintained for 30 min, as recommended by the manufacturer. Cells were then by The University of Iowa, Department of Biological Sciences, fixed in 1% paraformaldehyde in PBS, washed in PBS followed Iowa City, IA).
by distilled water, dried, and mounted using Prolong (Molecular The epitope-specific antiserum CTermB was prepared as deProbes) to reduce fading. Cells were examined under fluorescence scribed previously (10) . Based on the antigenicity index of microscopy using a Texas Red filter. Cytotoxicity was also assessed preproSP-B, the peptide sequence Leu 310 -Leu 329 was chosen for using an LDH assay on culture media using the Cytotoxicity Detecproduction of synthetic peptide by the Merrifield method by the tion kit (Roche Molecular Biochemicals, Mannheim, Germany) Nucleic Acid/Protein Core, Children's Hospital of Philadelphia.
according to the manufacturer's instructions. Peptide purity was confirmed by mass spectroscopy. The synthetic peptide was conjugated to Keyhole Limpet Hemocyanin and injected in Freund's adjuvant into New Zealand rabbits by Strategic
Long Term Inhibitor Studies
Biosolutions, Inc. (Ramona, CA). Antiserum was screened for reactivity against the immunizing peptide by immunodot blot and Undifferentiated alveolar epithelial cells were cultured for 24 h in Waymouth medium plus either DMSO or E-64 at 10-100 M Western immunoblot assay.
(stock 10 mM in DMSO; final concentration DMSO 0.1%). many), and immunoreactivity was visualized by incubation with a Media Ϯ E-64 was then supplemented with DCI for up to 7 d with secondary 5-nm gold-coupled antibody diluted in blocking buffer. daily changes of media. Cells were either frozen at -70ЊC for Control experiments were performed by omission of the primary protein analysis or fixed for either electron microscopy or immunoantibodies. Examination of labeled ultrathin sections was conhistochemistry.
ducted using an EM 900 (LEO, Oberkochen, Germany) at an accelerating voltage of 50 kV.
Western Immunoblotting RT-PCR
Western immunoblotting was accomplished using previously described procedures (10 
Immunofluorescence Cytochemistry
trations of the specific primers (SP-B, Cathepsins H, P/Z, V, X) Immunofluorescence staining was accomplished using previously were 0.5 M, and for GAPDH 0.1 M. The following primers described procedures (6) . Briefly, cells were fixed in 1% paraformwere used for RT-PCR: GAPDH sense-ACCACAGTCCATGCC aldehyde in PBS followed by washes in PBS with 5 mM NH 4 Cl, ATCAC, antisense-TCCACCACCCTGTTGCTGTA; SP-B senseand were stored at -70ЊC until immunostaining was performed.
AGGACATCGTCCACATCCTT, antisense-GAGCAGGATGAC After incubation in sodium borohydride and blocking in primary GGAGTAGC; Cathepsin H sense-CAACAATGGGAACCACA antibody host serum, slides were incubated overnight in primary CAT, antisense-GCAAAGCTCACAGGGTTGTA; Cathepsin O antibody at 4ЊC. In some cases, Triton X-100 was omitted from sense-AGATGAAATGCCAAAAGCAC; antisense-GCTTCTGT the blocking and antibody diluent solutions to improve antibody GCTGGAGGTTTGT; Cathepsins P and Z sense-AGCTGTGGA sensitivity. Secondary antisera were applied after washing and the ATAATGGCAAC; antisense-GCTGACTGCATCATTGTGAG; slides incubated at 4ЊC for 2 h. We used Alexa488 and/or Alexa594
Cathepsin V sense-GTACCAGTGGAAGGCAACAC antisenseconjugated to rabbit or mouse IgG as secondary antisera (Molecu-CCTCCGTTCTCCTTGACATA Cathepsin X sense-GAAGGTA lar Probes). Slides were washed, air dried, and mounted using GAGCCCCAGACTC, antisense-AAACCGCATGGTTCAGA Prolong (Molecular Probes, Eugene, OR) to reduce fading. Fluo-TTA. Cathepsins P and Z have 99% nucleotide homology and rescence was examined with an Olympus 1X70 microscope and the primers chosen do not discriminate between the two. After Metamorph imaging system. optimizing PCR conditions for each primer set, PCR was performed on 1 g cDNA using the following protocol: 
Electron Microscopy
of the final reaction (5 l) were run on 2% agarose gels with Undifferentiated epithelial cells were cultured for 5 and 7 d in DCI ethidium Br, and UV images obtained. Each PCR product was or DCI ϩ 100 M E-64. Cells were fixed in 2.5% glutaraldehyde in sequenced by the Nucleic Acid and Protein Core Facility of the cacodylate buffer, postfixed in 1% osmium tetroxide, and embedChildren's Hospital of Philadelphia and the sequence verified by ded and sectioned as previously described (19) . Two blocks were comparison to sequences contained within the GenBank database. prepared and sectioned from each experimental group. Ultrathin sections were examined by transmission electron microscopy in the Biomedical Imaging Core of the University of Pennsylvania School of Medicine. Electron micrographs of 6-8 grid subdivisions per Enzyme Assay for Cathepsin H section were taken at ϫ2,500, ϫ10,000 and ϫ30,000 magnification.
Cell pellets (1-4 ϫ 10 6 ) were sonicated on ice in phosphate buffer pH 6.8 containing 1 mM EDTA. The assay was performed at 37ЊC in 0.1 M phosphate buffer containing 1 mM EDTA and 10 mM
Immunoelectron Microscopy cysteine at pH 6.8 with Arg-AMC as a substrate (20) . For inhibition of serine, aspartic, and metallo proteinases di-isopropyl-fluoroSix single human donor lungs were fixed by instillation of a mixture phosphate (DFP, 10 M; Sigma, Deisenhofen, Germany), pepsof 4% formaldehyde (prepared from freshly depolymerized paratatin A (1 mM; Sigma) and Ethylene glycol-bis(2-aminoethyformaldehyde) and 0.1% glutaraldehyde in 0.2 M Hepes buffer.
lether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA, 100 M; Sigma) was Donor lungs were used for investigation only if they could not be added. To document the specificity of the enzymatic substrate made available for another suitable recipient by The Eurotranscleavage, assays were performed in the presence or in absence plant Foundation Center (Leiden, The Netherlands). Systematic of 5 M trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane uniform random lung samples were processed for immunoelectron (E64; Sigma), an inhibitor of cysteine proteases, which blocks the microscopy as previously described (14) . To localize SP-B and substrate cleavage. The relative cathepsin H activity was calculated cathepsin H, we prepared serial sections and labeled alternating from the difference in AMC release of corresponding samples with sections with rabbit anti-cathepsin H or SP-B antisera (anti-SP-B, and without E64. The enzymatic activity was expressed as relative a gift of Dr. J. Whitsett, Cincinnati, OH; anti-cathepsin H, a gift of H. Kirschke, Institute of Physiological Chemistry, Halle, Geractivity per total protein in the cell lysates. Figure 2 . DMSO-exposed control cells exhibited proSPguanidino)butane, is a water-soluble inhibitor of Cathepsins B 42 processing to mature 8 kD SP-B within 1-2 h and accu-B, H, L and calpain that has been used in cell culture sysmulation of labeled SP-B 8 , as previously described in cells tems (20, 21) . To examine the effects of cysteine protease cultured in the absence of DMSO (19) . A 9-kD intermediate inhibition during type 2 cell differentiation, we cultured was first detected at 2 h, but did not accumulate in later undifferentiated lung epithelial cells from second trimester samples, indicating a precursor-product relationship with human fetal lungs in the presence of DCI Ϯ 10-100 M rapid kinetics for conversion to SP-B 8 as previously de-E-64. There was no evidence of cytotoxicity by LDH assay scribed. In the presence of E-64, proSP-B 42 was cleaved to and Carboxy-SNARF-1 fluorescence, through 7 d in culture SP-B 25 , followed by cleavage to proteins ranging between with E-64 (not shown). Western immunoblotting of cells 9 and 12 kD which accumulated over the 4-h chase period; cultured in DCI alone showed increasing SP-A and SP-B 8 there was delayed appearance of SP-B 8 and small amounts production as previously described (18) , and GAPDH did detected at 4 and 8 h, at levels less than in DMSO-exposed not change over time under these conditions (Figure 1) . cells. The presence of E-64 during cell culture did not affect To more precisely characterize the kinetics of SP-B processing Ϯ E-64, phosphorimager data were quantified GAPDH expression, nor did it alter the accumulation of SP-A over the culture period. E-64 delayed the accumulaby densitometry. The densitometric units within each band were first corrected for the Cys/Met content as previously tion of SP-B 8 , and was associated with accumulation of a 9-kD intermediate. This intermediate was also identified described (10) . We were able to resolve and quantify 42-, 25-, 12-, 9-, and 8-kD bands (n ϭ 3 experiments) for analysis. by the NFlank antiserum that detects amino acids Gln SP-B protein forms; this is referred to as the initial incorpomore diffuse pattern of staining in contrast to the intense lamellar body pattern of staining in untreated type 2 cells. rated label post-pulse. Corrected densitometric units for each SP-B form were then expressed as the percent of Immunostaining for markers of endoplasmic reticulum, Golgi, and early endosomes were not different in the presthe initial incorporated label, and the percentage change between protein intermediates was calculated. Loss of label ence of E-64 compared with control cells ( Figure 3B ). However, the distribution of Lamp-1, a lysosomal transmemfrom the 42-kD proSP-B was not different Ϯ 100 mM E-64 (28.3 Ϯ 5.5%/h control, 23.9 Ϯ 4.7%/h E-64, mean Ϯ SE; brane protein present in the limiting membrane of lamellar bodies as well as the small vesicles within multivesicular P ϭ .46). There was a significant decrease in the rate of accumulation of mature SP-B in E-64-treated cells (16.8 Ϯ bodies (22) , was altered by E-64 treatment. Control cells showed vesicle and lamellar body staining described pre-4.8%/h control, 0.8 Ϯ 0.4%/h E-64, mean Ϯ SE; P Ͻ 0.01).
viously (6) , whereas E-64-treated cells had more extensive, E-64 Alters Type 2 Cell Phenotype and Lamellar Body coarse Lamp-1 immunostaining.
Genesis during Differentiation
To clarify the effects of cysteine protease inhibition on lamellar body formation, we examined transmission elecNile red is a lipophilic vital stain that identifies lamellar bodies of alveolar type 2 cells (19) . In Figure 3A nally, as has been described by others in human type 2 cells tinued to display significant amounts of poorly organized electron-dense material but also show evidence of mature lamellar bodies (Figures 5A-5C ) and secreted surfactant ( Figure 5D ). of DCI alone ( Figure 4A ) demonstrated microvilli and increasing numbers of lamellar bodies as previously reported E-64 Alters SP-C Post-Translational Processing (18); 80-95% of cells within each grid subdivision examined To examine the effects of E-64 on SP-C processing, we exhibited this phenotype. The lamellar bodies were spheriused the antiserum NProSP-C to detect accumulated SP-C cal with tightly packed lamellae in a concentric configuraprecursors. This antiserum does not detect mature SP-C 3.7 . tion in cross-section or with lamellae emanating from an electron-dense projection core when sectioned longitudiWestern immunoblotting of type 2 cells cultured for 5-7 d panels, U) and SP-B mRNA increased under the influence of DCI ( Figure 7A , lower panels, D). This was consistent with other reports of SP-B mRNA expression in second trimester human fetal lung (11) . Importantly, no SP-B product was amplified from fetal heart, liver, or kidney. Cathepsin H was also detected in undifferentiated cells and increased in response to DCI, consistent with prior microarray studies (18) . By comparison, in the samples examined, Cathepsins O, P/Z, V, and X were not detected in either were used to further define the subcellular location of Cathepsin H in relation to SP-B within type 2 cells. At the ultrastructural level, SP-B and cathepsin H localized to multivesicular, composite, and lamellar bodies. In lamellar in the presence of hormones ( Figure 6, lanes 3 and 4 ) bodies of adult human type 2 cells, both localized over the showed evidence of proSP-C 21 , but very little SP-C intermeprojection core with weak labeling for cathepsin H also diate, as also noted in adult lung (lane 1). Cells cultured in along the limiting membrane of lamellar bodies ( Figure 7C ). the presence of E-64 exhibited a 10-kD precursor (lanes 5
Cathepsin H activity was assayed in cells using the suband 6 ), similar in M r to proSP-C precursor forms which strate Arg-AMC, which is specific for Cathepsin H (20) . accumulate in SP-B-deficient lung (lane 2).
When compared with freshly isolated undifferentiated epithelial cells, hormone-treated cells exhibited a 2-to 3-fold Cathepsin H Is a Candidate Protease for SP-B Processing increase in Cathepsin H activity after 3 and 5 d in culture An extensive review of the literature indicated that only a ( Figure 7D ), which was consistent with increased Cathepsin subset of lysosomal cysteine proteases could be responsible H expression noted by RT-PCR. Cells cultured in hormones for the cysteine protease activity within type 2 cells. Knockwith increasing concentrations of E-64 showed a dose-deout models for Cathepsins B, C, K, L, and S display no pendent decrease in Cathepsin H activity (n ϭ 2 experiments). pulmonary pathology nor neonatal lethality, and thus were not considered plausible candidates for SP-B proteolysis.
Discussion
Those cysteine protease Cathepsins known to be expressed in lung or not previously examined for pulmonary expres-
The biosynthesis of SP-B requires extensive remodeling of sion included Cathepsins H, O, P, Z, V, and X (14, (24) (25) (26) (27) .
the proprotein precursor, but the enzymes necessary for RT-PCR of fetal human lung, heart, kidney, and liver tissue this process are largely undefined. In these studies, we have followed by sequence analysis of the products confirmed shown that cysteine protease inhibition altered processing the correct detection of Cathepsins H, O, P/Z, V, and X of proSP-B in human type 2 cells. More specifically, the using our primers. We then developed multiplex RT-PCR final step in SP-B processing is sensitive to inhibition by the for Cathepsins H, O, P/Z, V, X, and SP-B in conjunction cysteine protease inhibitor E-64. Furthermore, inhibition of with GAPDH to semiquantitatively assess Cathepsin this step in processing, by blocking the formation of mature mRNA expression. The conditions used for amplification SP-B, results in similar features to those previously deresulted in linear increases in both products with increasing scribed in both inherited SP-B deficiency in humans and in input cDNA (not shown). RNA from fetal heart, liver, and SP-B knockout mice, specifically disrupted lamellar body kidney ( Figure 7A , upper panels; H, L, K, respectively), genesis, and aberrant SP-C processing. To begin to identify and samples of undifferentiated lung epithelial cells and in the lysosomal cysteine protease responsible for these efvitro differentiated type 2 cells from three separate fetuses fects, we showed that the most likely candidate is Cathepsin (gestational ages 16-18 wk), were examined. Cathepsins H, H. Together, these studies represent the first description of P/Z, and X were detected in fetal heart, liver, and kidney inhibition of SP-B proteolytic processing in human alveolar using our RT-PCR conditions, whereas Cathepsins O and type 2 cells. V were only detected in fetal kidney. These expression SP-B proteolytic processing involves multiple steps, reprofiles were consistent with prior reports of Cathepsin sulting in release of the mature 79 amino acid SP-B protein expression. Small amounts of SP-B mRNA were detected in from the larger 381-kD preproprotein. Early studies suggested that proSP-B underwent complete cleavage of the isolated undifferentiated epithelial cells ( Figure 7A , lower and V (CTSV) only in fetal kidney, whereas Cathepsins P/Z (CTSP/Z) and X (CTSX) were identified in fetal heart, liver, and kidney. Only Cathepsin H (CTSH) and SP-B were detected in cells from fetal lung. RNAs for Cathepsin H and SP-B were detected in undifferentiated lung epithelial cells and increased with in vitro differentiation of type 2 cells. (B ) Western immunoblotting of cells differentiated for up to 6 d Ϯ 100 M E-64. Expression of single chain 28-kD Cathepsin H (CTSH, upper arrowhead) increased during in vitro differentiation in both the presence and absence of E-64, whereas expression of the 22-kD heavy chain fragment accumulates to a greater degree in the presence of E-64 (n ϭ 3). (C ) Cathepsin H and SP-B localize in lamellar bodies of adult human lung tissue. Serial thin sections of adult human lung were exposed to primary antisera for SP-B (left) and Cathepsin H (right). Immunogold particles from both antisera are shown localizing over the projection core of lamellar bodies. (D ) E-64 inhibits Cathepsin H activity in type 2 cells. Cathepsin H activity assay performed on freshly isolated undifferentiated alveolar epithelial cells (no DCI) and cells cultured for 3 and 5 d in DCI Ϯ 10, 50, or 100 M E-64. With induction of type 2 cell phenotype by DCI, Cathepsin H activity increased 2-to 3-fold (mean Ϯ SD; n ϭ 2 experiments). In the presence of E-64, Cathepsin H activity was inhibited in a dose-dependent fashion.
aminoterminus followed by cleavage of the carboxytermiwithin the type 2 cell and cleaved in a prelamellar body compartment. It is well known that the first cleavage of nus to release mature SP-B (reviewed in Ref. 1). Our prior studies expanded upon the original processing scheme, the aminoterminus is a non-type 2 cell-specific process occurring in cell lines (28, 29), whereas the latter steps, showing that proteolysis of the aminoterminus occurred in two steps within distinct compartments of the type 2 cell specifically cleavages of the carboxyterminus and residual aminoterminal propeptide, are type 2 cell-specific. It is the (10). Our current studies lend support to the processing scheme (depicted in Figure 8 ) in which a residual portion cell-type-specific steps in processing that occur in more distal compartments of the type 2 cell, in closer proximity of the aminoterminus is exposed in proximal compartments display pulmonary pathology (30) (31) (32) (33) (34) . Tissue surveys by Western or Northern blot analysis have shown that Cathepsins F, W, M, and Q are also absent from adult lung tissue (35) (36) (37) (38) . This narrowed the list of candidate proteases to Cathepsins P and Z (which share 99% DNA sequence homology), H, O, V, and X, all of which have been described previously in adult lung tissue (24-27, 39, 40) and/or specifically in alveolar type 2 cells (14, 16) .
Our recent report of microarray analysis of in vitro differentiation of type 2 cells (18) showed a 2.7-fold induction of Cathepsin H and no significant expression of Cathepsin O in type 2 cells; Cathepsins P, Z, V, and X were not represented on the arrays used. We have now demonstrated by multiplex RT-PCR no expression of Cathepsins O, P, Z, V, and X in second trimester human fetal lung epithelial cells, and inducible expression of only Cathepsin H during The advantages of our model system include the enrichment of type 2 cells during isolation and the absence of contaminating macrophages in fetal lung tissue. Cathepsin H displayed a similar time course of expression as SP-B to the lamellar body (6) . The aminoterminus remnant in during type 2 cell differentiation and localized with SP-B in association with mature SP-B constitutes the 9-kD intermemultivesicular body, composite bodies, and lamellar bodies diate that accumulates upon E-64 inhibition during pulsewithin type 2 cells by immunoelectron microscopy. Furtherchase studies in differentiated type 2 cells and during difmore, Cathepsin H activity in type 2 cells, as determined ferentiation of type 2 cells in vitro (Figures 1 and 2 ). Our by cleavage of the specific substrate Arg-AMC, was inhibprevious studies indicated that cleavage of the residual aminoterminus occurred in a post-Golgi, pre-lamellar body ited by the addition of E-64 to the culture media. We therefore conclude that the most likely cysteine protease particicompartment (6) . E-64 treatment caused no gross disruption of ER, Golgi, or early endosomes by immunocytochemistry, pating in SP-B processing and inhibited by E-64 was Cathepsin H. although more detailed functions of these compartments were not explored. The compartment most significantly afTwo additional observations from protease inhibition require further investigation: the presence of a second interfected was a Lamp1-positive compartment, which by immunostaining appeared engorged within the E-64-treated type mediate of ϳ 12 kD in pulse chase studies and the partial inhibition of this step in SP-B processing. Cathepsin H is 2 cells when compared with untreated cells. Lamp1 is a lysosomal transmembrane protein that has been localized a cysteine protease with unique aminopeptidase activity (20, 41) . It behaves as both an endopeptidase, like Cathepto both multivesicular bodies and lamellar bodies in type 2 cells (22) . Electron microscopy demonstrated increased sins B, L, and K, but also as an aminopeptidase (42, 43) . Cathepsin H has preference for cleavages proximal to amino numbers of multivesicular bodies and no normal lamellar bodies (Figure 4 -Val-Pro. Alternative cleavages at these sites could generate 9-to 12-kD proteins The family of cysteine proteases is large and includes both lysosomal and nonlysosomal proteases (21) . Because detectable by our antisera. In fact, the region of proSP-B from Cys 143 to Gln
200
, lying distal to the previously described SP-B processing has been localized within lysosomal/prelamellar body compartments, specifically the multivesicular saposin-like structural arrangement of the aminoterminus, contains 13 prolines often in Pro-X-Pro configuration. It is body, we focused on the family of lysosomal cysteine proteases. The largest group of lysosomal cysteine proteases is the therefore reasonable to speculate that additional cleavage sites for Cathepsin H proteolysis are contained within this Cathepsin family, although not all cathepsins are cysteine proteases. Of the 14 well-characterized cysteine protease region and that additional intermediates may exist that as yet have not been detected. Additional studies will be reCathepsins (specifically, B, C, F, H, K, L, M, O, P, Q, S, W, X, and Z), many could be excluded from consideration.
quired to confirm this, including sequencing of these 9-and 12-kD intermediates from E-64-treated cells. Knockout models for Cathepsins B, C, K, L, and S do not Despite the use of 100 M E-64, we consistently obbody compartment (6) . We have now shown ultrastructural localization of both SP-B and Cathepsin H in multivesicular served gradual accumulation of SP-B 8 due to incomplete enzyme inhibition. In our enzyme activity assays, there was bodies, composite bodies, and lamellar bodies. Furthermore, inhibition of the distal processing step by E-64 ima wider variation in activity at 5 d compared with 3 d, suggesting that residual activity remained that could explain paired lamellar body formation, favoring accumulation of multivesicular bodies, and altered cleavage of the SP-C the accumulation of SP-B 8 . Although E-64 is highly specific for cysteine proteases and a very effective inhibitor of Caaminoterminus. Large collections of electron-dense material coalesced in membrane-limited structures within E-64-thepsin B, it is not as effective an inhibitor of Cathepsin H, as indicated by a higher IC 50 and lower K I , compared treated cells were suggestive of attempted formation of lamellae, which may reflect the presence of some SP-B 8 with other cysteine proteases of the Cathepsin B class (21) . E-64 is also a polar molecule that crosses membranes poorly detectable by Western immunoblotting in E-64-treated cells. In fact, with increasing time in culture, we saw increasand has been shown in other cell types to be taken up by endocytosis (45). Although this was advantageous for our ing numbers of lamellar bodies in E-64-treated cells in association with an escape from E-64 inhibition of SP-B experiments because the endocytic pathway of type 2 cell intersects with both multivesicular bodies and lamellar bodprocessing (Figures 2 and 5 ), suggesting that a critical mass of SP-B 8 is required for lamellar body genesis. These results ies (46) (47) (48) , it may also explain the incomplete inhibition of SP-B processing in our studies, especially over time.
correlate well with prior in vitro characterization of the dose dependency of lipid membrane fusion on SP-B 8 conWe also observed a dose-and time-dependent increase the expression of the 22-kD form of Cathepsin H, which also has centration (51). Because sequential processing of SP-B followed by SP-C is achieved through the accessibility of their enzymatic activity. Studies aimed at specifically eliminating protein intermediates to Cathepsin H, inhibition of this Cathepsin H expression to further clarify these issues are SP-B processing step would impair lysis of small vesicles in progress.
within multivesicular bodies and thus inhibit cleavage of There has been much speculation over the rationale for SP-C intermediates. Alternatively, aberrant SP-C promultistep processing of SP-B. The most popular theory is cessing might be due simply to E-64 inhibition of Cathepsin that multistep processing allows for caging of this extremely H activity. hydrophobic, fusogenic protein. The secretory pathway and
In conclusion, our data are consistent with participation specifically the lipid-rich lamellar body provide the approof a cysteine protease in the processing of SP-B and lamellar priate organellar environment for liberating the mature probody genesis. We have demonstrated for the first time that tein. Although the mechanisms governing lamellar body inhibition of SP-B processing produces a type 2 cell phenoformation, concentration of surfactant-specific lipids, and type similar to that of inherited SP-B deficiency, including accumulation of surfactant protein components are poorly absent lamellar bodies, increased numbers of multivesicular understood, current theories of lamellar body genesis (2, bodies, and aberrant processing of SP-C. We have also 49) and experimental evidence of SP-C proteolytic proshown that the most likely candidate cysteine protease is cessing (5, 50) suggest that the lamellar body is derived from Cathepsin H. Although our data are compelling, they are maturation of multivesicular bodies enriched in surfactant not yet conclusive. Given the number of cysteine proteases phospholipid. The interior vesicles of multivesicular bodies and the broad inhibition profile of E-64, it is possible that contain the integral membrane protein intermediate of an as yet unknown, type 2 cell-enriched cysteine protease proSP-C oriented so that the aminoterminus is within the is being inhibited by E-64. We must also consider the possilumen of these multivesicular body vesicles. Activation of bility that a cysteine protease is critical for some other the fusogenic properties of SP-B would then allow for disproteolytic cleavage of an as yet unidentified protease or ruption of the small vesicles and exposure of the proSP-C protein necessary for SP-B processing or trafficking or for aminoterminus to proteases within the multivesicular body lamellar body genesis. Nonetheless, the induction of cathepmatrix. Our model system provides a powerful tool for sin H during type 2 cell maturation, and its ultrastructural dissecting the process of lamellar body genesis. There are localization with SP-B, suggest a critical role for cathepsin no cell lines that faithfully duplicate the processing of SP-B H during lung development and maturation. and the formation of lamellar bodies. In addition, adult type 2 cells do not maintain their differentiated phenotype
